期刊文献+

来曲唑对大鼠子宫内膜异位症模型VEGF及MVD表达的影响 被引量:2

Effect of letrozole on expressions of VEGF and MVD in endometriotic rats
原文传递
导出
摘要 目的探讨来曲唑对大鼠子宫内膜异位症(EM)模型异位病灶中血管内皮生长因子(VEGF)及微血管密度(MVD)表达的影响,及其治疗EM的作用机制。方法行自体移植建立EM大鼠模型,将建模成功大鼠随机分为来曲唑组及盐水对照组,比较口服来曲唑或盐水前后EM大鼠异位病灶体积改变,并采用免疫组化法检测各组异位内膜VEGF及MVD的表达变化。结果来曲唑组异位病灶体积明显缩小或萎缩,与对照组比较差异有统计学意义(P<0.05)。来曲唑治疗后VEGF、MVD在异位内膜中表达降低(P均<0.05)。结论来曲唑对大鼠异位囊肿的体积影响明显,短时间内就能起到明显效果。可能通过降调VEGF、MVD在异位内膜组织中的表达而发挥治疗作用。 Objective To study the different expression patterns of vascular endothelial growth factor(VEGF)and micro-vessel density(MVD)in tissues of endometriosis in rat models after letrozole therapy,and to explore the underlying mechanism of letrozole treatment for endometriosis(EM).Methods Rat models were established by autologous transplantation of uterine tissues to an ectopic site beside the uterines.Then the successful rat models were randomly divided into the NS control group and the Letrozole(p.o.)treated groups.To compare the difference of ectopic lesion volumes after the treatment,an immunohistochemical method was used to detect VEGF and MVD expressions in tissues of endometriosis in the rat models.Results The volume of endometriotic tissues in the letrozole groups decreased compared with the control group(P0.05).The inhibitory effect of the drug significantly increased with the duration of treatment.Expressions of VEGF and MVD in tissues of endometriosis decreased after using letrozole.Compared with the control group,the differences were significant(P0.05).Conclusions The volume of the ectopic focus in rat models was obviously changed after letrozole treatment,and a significant effect appeared in a short time.Letrozole can treat EM through down-regulating expressions of VEGF and MVD in ectopic tissues.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第5期58-61,共4页 Journal of Shandong University:Health Sciences
基金 山东省教育厅科研基金资助项目(J06L26)
关键词 子宫内膜异位症 来曲唑 血管内皮生长因子 微血管密度 大鼠 Wistar Endometriosis Letrozole Vascular endothelial growth factor Microvessel density Rats Wistar
  • 相关文献

参考文献11

  • 1Remorgida V, Abbamonte H L, Ragni N, et al. Letrozole and norethisterone acetate in rectovaginal endometriosis[J]. Fertil Steril, 2007, 88 (3) : 724-726.
  • 2智明春,李兆艾.子宫内膜异位症血管生成研究进展[J].中国药物与临床,2005,5(2):118-120. 被引量:8
  • 3Jones R C. The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40, 972), levonorgestrel, danazol and ovarictomy on experimental endometriosis in the rat [J]. Acta Endocrinologica, 1984, 106: 282-288.
  • 4Kormo R, Yamakawa H, Utsunomiya H, et al. Expression of survivin and Bcl-2 in the normal human endometrium[J]. Mol Hum Reprod, 2000, 6(6) :529-534.
  • 5Mousa N A, Bedaiwy M A, Casper R F. Aromatase inhibitors in the treatment of severe endometriosis [ J ]. Obstet Gynecol, 2007, 109(6) : 1421-1423.
  • 6Fatemi H M, Al-Turki H A, Papanikolaou E G, et al. Successful treatment of an aggressive recurrent post-menopausal endometriosis with an Aromatase inhibitor[ J]. Reprod Biomed Online, 2005, 11 (4) :455457.
  • 7Ailawadi R K, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with petrozole and norethindrone acetatea: a pilot study [ J ]. Fertil Steril, 2004, 81(2) :290-296.
  • 8Goteri G, Lucarini G, Filosa A, et al. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata [ J ]. Fertil Steril, 2004, 81 (6) :1528-1533.
  • 9Tan X J, Lang J H, Liu D Y, et al. Expression of vaseular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis [ J ]. Fertil Steril, 2002, 78 (1) :148-153.
  • 10Wu M Y, Ho H N. The role of cytokines in endometriosis [ J ]. Am J Reprod Immunol, 2003, 49 (5) : 285-296.

二级参考文献16

  • 1Inan S,Kuscu NK,Vatansever S,et al. Increased vascular surface density in ovarian endometriosis. Gynecol Endocrinol,2003,17(2): 143-150.
  • 2Ota H,Tanaka T. Stromal vascularizatoin in the endometriosis during adenomyosis. Microsc Res Tech, 2003,60 (4): 445-449.
  • 3Goteri G,Lucarini G,Filosa A,et al. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril,2004,81(6): 1528-1533.
  • 4Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996,86(3):353-364.
  • 5Matsuzaki S,Canis M,Vaurs-Barriere C,et al. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod,2004,10(10):719-728.
  • 6Absenger Y,Hess-Stumpp H,Kreft B,et al. Cyr61 ,a deregulated gene in endometriosis. Mol Hum Reprod,2004,10(6):399-407.
  • 7Schindl M,Birner P,Obermair A,et al. Increased microvessel density in adenomyosis uteri. Ferti Steril,2001,75( 1):131-135.
  • 8Khan KN,Masuzaki H,Fujishita A,et al. Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium. Fertil Steril, 2003,79( 1 ):173-181.
  • 9Nisolle M, Casanas-Roux F, Donnez J. Early-stage endometriosis:adhesion and growth of human menstrual endometrium in nude mice. Fertil Steril,2000,74(2):306-312.
  • 10Tan X J, Lang JH, Liu DY, et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril,2002,78(1):148-153.

共引文献7

同被引文献13

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部